51 research outputs found

    Neodymium-YAG Laser Posterior Capsulotomy

    No full text

    Preface

    No full text

    Myopia and Unexpected Intraocular Pressure Elevations After Neodymium-YAG Capsulotomy

    No full text
    TO THE EDITOR. —Transient intraocular pressure (IOP) elevations following neodymium-YAG laser posterior capsulotomy have been reported.1-5 No relation between the refractive error or axial length or both and the prevalance or severity of IOP elevation has been suggested. Trabecular meshwork obstruction with capsular remnants, cortical debris, and inflammatory cells has been proposed to explain the decreased outflow facility.3,5 We recently treated two patients (three eyes) with high axial myopia who developed unusually high IOP elevations. The IOP spike was not associated with significant intraocular inflammation, anterior chamber debris, or acute pupillary block. REPORT OF CASES.—CASE 1. —A 25-year-old woman with best corrected visual acuity of 20/20+ (aphakic correction, +3.50 +1.25 × 120, axial length, 25.4 mm) after extracapsular cataract extraction (ECCE) without IOL implantation underwent a 2.0-mm posterior capsulotomy (Figure). The Q-switched pulses were as follows: two pulses per burst, 0.6 millijoule per pulse, with

    Acute Elevations of Intraocular Pressure Following Nd:YAG Laser Posterior Capsulotomy

    No full text
    We performed applanation tonometry preoperatively, hourly for the first four postoperative hours and on the first postoperative day in 66 eyes after Nd:YAG laser posterior capsulotomy in order to determine the nature of the acute intraocular pressure (IOP) elevation and the risk factors involved. Forty-one percent of eyes developed an intraocular pressure greater than 30 mmHg and 14% greater than 40 mmHg. The IOP spike occurred on the second postoperative hour in 35% of eyes. Patients with controlled glaucoma prior to capsulotomy had a significantly lower mean IOP rise than patients without glaucoma. Eyes with posterior chamber IOLs were less likely to develop an lOP greater than 30 mmHg than were aphakic eyes without IOLs. There was no correlation between the laser energy or the size of the capsulotomy and the IOP ris

    Ocular rosacea: The often‐overlooked component of rosacea

    No full text
    Abstract Ocular rosacea is a chronic inflammatory condition that affects the eyes and periocular skin as part of the broader cutaneous rosacea skin disease. Cutaneous rosacea is common, affecting approximately 5.5% of the global population, where up to 72% of patients will develop ocular involvement either before or after the cutaneous disease. Clinical features of ocular rosacea include Meibomian gland disease, blepharitis and conjunctivitis. Ocular rosacea reduces quality of life through various potential mechanisms including anxiety, social withdrawal and physical discomfort. If left untreated, ocular rosacea can reduce visual acuity and in severe cases, vision loss. Several topical and systemic treatment options are available, with efficacies based on their anti‐inflammatory properties. This review focuses on the clinical features of ocular rosacea, differential diagnoses and treatment options with the aim of aiding clinicians involved in the care of rosacea patients to better identify onset of the ocular manifestations of rosacea and prevent its severe complications
    corecore